Clinical Observation on Suxuetong Injection with ACEI/ARB for Early Diabetic Nephropathy_West China Medical Journal

Authors：

1 The Second Hospital of Liangshan,Xichang Sichuan 615000;2Department of nephrology,West China Hospital,Sichuan University,Chengdu 610041, China;

Corresponding?author：

Keywords：

疏血通注射液; 早期糖尿病腎病

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的:觀察采用疏血通注射液聯合ACEI/ARB治療早期糖尿病腎病(DN)的療效。方法:將78例2型DN患者隨機分為對照組(ACEI/ARB)和治療組(ACEI/ARB+疏血通注射液),療程4周。比較兩組治療前和治療后尿微量白蛋白(mAlb),Scr、BUN等指標的變化。結果:(1)治療后治療組和對照組尿白蛋白均顯著下降(P lt;0.01,P lt;0.05),治療組比對照組下降更為明顯(P lt;0.05)。(2)治療后兩組血漿白蛋白均增加(P lt;0.01),治療組與對照組治療后比較無明顯差異(P gt;0.05)。(3)治療后兩組Scr、BUN、TC、TG和血鉀均無明顯變化。結論:聯合應用疏血通注射液能有效減少早期DN患者的蛋白尿,改善腎功能。

Citation： DAI Pin,CAI Wenjing,LIAO Yanli,et al. Clinical Observation on Suxuetong Injection with ACEI/ARB for Early Diabetic Nephropathy. West China Medical Journal, 2009, 24(7): 1748-1750. doi: Copy

1.	ESRD Incidence Study Group,STEWART JH,MCCREDIE MR,WILLIAMS SM.Geographic,ethnic, agerelated and temporal variation in the incidence of endstage renal disease in Europe, Canada and the AsiaPacific region,1998-2002[J].Nephrol Dial Transplant, 2006,21(8):2178-83.
2.	ZUO L,WANG M;Beijing Hemodialysis Quality Control and Improvement Center.Current status of hemodialysis treatment in Beijing, China[J].Ethn Dis,2006,16(2 Suppl 2):S2-31-4.
3.	K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.National Kidney Foundation- Disease Specific Society.2004 May. 290 pages.NGC:003985.
4.	American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J].Diabetes Care,1997,20:1183.
5.	WITTMANN I,DEGRELL P,KOMAROMY A, et al.The role of angiotensin Ⅱ Atireceptor antagonists in renal and cardiac protection in type2 diabetesmellitus[J].Ital Heart J Suppl,2003,4(3):210-216.
6.	PARVING HH,ANDERSEN S,JACOBSEN P, et al.Angiotensin receptor blockers in diabetic nephropathy:real and cardiovascular end points[J].Semin Nephrol,2004,24(2):147-157.
7.	RODONDI N,YERLY P,GABRIEL A, et al.Microalbuminuria,but not cystatin C,is associated with carotid atherosclerosis in middleaged adults[J].Nephrol Dial Transplant, 2007,22(4):1107-14.
8.	WADA M, NAGASAWA H, KURITA K, et al.Microalbuminuria is a risk factor for cerebral small vessel disease in communitybased elderly subjects[J]. J Neurol Sci, 2007,255(1-2):27-34.
9.	STRIPPOLI GF, DI PAOLO S, CINCIONE R, et al. Clinical and therapeutic aspects of diabetic nephropathy[J]. J Nephrol,2003,16:487-499.
10.	NOSADINI R, VELUSSI M, BROCCO E, et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate[J]. Diabetes, 2000,49:476-484.
11.	SUN X, ZHOU X, YAN H. Hypercoagulation aggravates renal dysfunction in patient with diabetic nephropathy[J]. Zhonghua Xue Ye Xue Za Zhi, 2001,22(9):476-7.
12.	ASAKAWA H, TOKUNAGA K, KAWAKAMI F. Elevation of fibrinogen and thrombinantithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy[J]. Diabetes Complications,2000,14(3):121-6.
13.	陳華友,黃靜,蔣芝君,等.抗凝良藥水蛭素的研究進展[J].生物學通報,2003,38(3):3.
14.	劉捷,張秀杰,李輝.疏血通治療腦梗塞療效觀察[J].中華中西醫結合雜志,2001,22(2):31-32.
15.	VIBERTI G,WHEELDON NM.Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus[J].Circulation,2002,106(6):672.

1. ESRD Incidence Study Group,STEWART JH,MCCREDIE MR,WILLIAMS SM.Geographic,ethnic, agerelated and temporal variation in the incidence of endstage renal disease in Europe, Canada and the AsiaPacific region,1998-2002[J].Nephrol Dial Transplant, 2006,21(8):2178-83.
2. ZUO L,WANG M;Beijing Hemodialysis Quality Control and Improvement Center.Current status of hemodialysis treatment in Beijing, China[J].Ethn Dis,2006,16(2 Suppl 2):S2-31-4.
3. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.National Kidney Foundation- Disease Specific Society.2004 May. 290 pages.NGC:003985.
4. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J].Diabetes Care,1997,20:1183.
5. WITTMANN I,DEGRELL P,KOMAROMY A, et al.The role of angiotensin Ⅱ Atireceptor antagonists in renal and cardiac protection in type2 diabetesmellitus[J].Ital Heart J Suppl,2003,4(3):210-216.
6. PARVING HH,ANDERSEN S,JACOBSEN P, et al.Angiotensin receptor blockers in diabetic nephropathy:real and cardiovascular end points[J].Semin Nephrol,2004,24(2):147-157.
7. RODONDI N,YERLY P,GABRIEL A, et al.Microalbuminuria,but not cystatin C,is associated with carotid atherosclerosis in middleaged adults[J].Nephrol Dial Transplant, 2007,22(4):1107-14.
8. WADA M, NAGASAWA H, KURITA K, et al.Microalbuminuria is a risk factor for cerebral small vessel disease in communitybased elderly subjects[J]. J Neurol Sci, 2007,255(1-2):27-34.
9. STRIPPOLI GF, DI PAOLO S, CINCIONE R, et al. Clinical and therapeutic aspects of diabetic nephropathy[J]. J Nephrol,2003,16:487-499.
10. NOSADINI R, VELUSSI M, BROCCO E, et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate[J]. Diabetes, 2000,49:476-484.
11. SUN X, ZHOU X, YAN H. Hypercoagulation aggravates renal dysfunction in patient with diabetic nephropathy[J]. Zhonghua Xue Ye Xue Za Zhi, 2001,22(9):476-7.
12. ASAKAWA H, TOKUNAGA K, KAWAKAMI F. Elevation of fibrinogen and thrombinantithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy[J]. Diabetes Complications,2000,14(3):121-6.
13. 陳華友,黃靜,蔣芝君,等.抗凝良藥水蛭素的研究進展[J].生物學通報,2003,38(3):3.
14. 劉捷,張秀杰,李輝.疏血通治療腦梗塞療效觀察[J].中華中西醫結合雜志,2001,22(2):31-32.
15. VIBERTI G,WHEELDON NM.Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus[J].Circulation,2002,106(6):672.

West China Medical Journal

Clinical Observation on Suxuetong Injection with ACEI/ARB for Early Diabetic Nephropathy

Abstract Full text Figures/Tables Video References Cited by

Format

Content